ArticleFrontiers in medicine2026
Reconstruction of large truncal defects post-malignant tumor excision using triple rhomboid flaps.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The reconstruction of large defect after skin malignant tumor excision is a challenge in dermatologic surgery and reconstructive surgery. This study describes the use of triple rhomboid flaps for reconstruction of large truncal defects after excision of malignant skin tumors.The research aims to present an accessible and efficacious method for reconstructing large truncal defects using triple rhomboid flaps. Methods: Between April 2023 and June 2025, nine patients with large skin malignant tumors in the trunk, with dimensions ranging from 5×5 cm to 17×15 cm, were treated at our hospital. We use triple rhomboid flaps to reconstruct the defects. Results: No major postoperative complications were seen. All flaps survived, and incisions healed in a single phase. Both medical professionals and patients expressed satisfaction with the results. Conclusion: In this small retrospective case series, the triple rhomboid flap appeared to be a feasible, practical, and easy-to-perform reconstructive strategy for selected large truncal defects after malignant skin tumor excision. Its simple design and straightforward operative procedure may make it a useful option for dermatologic surgeons, particularly in settings where complex microsurgical reconstruction is not routinely available. Further studies with larger cohorts, longer follow-up, and comparative designs are needed to validate its indications, safety, and long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.